Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. SYK has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
SYK stock price ended at $375.56 on Friday, after rising0.62%
The Stryker Corp stock price increased by 0.62% on the last trading day (20 Jun 2025), rising from 374.89 to 375.56. Throughout the last trading session, the stock experienced a fluctuation of 1.10% , ranging from a day low of $373.775 to a day high of 377.9. The price has declined in 7 of the last 10 days, resulting in a total change of -1.97% during this period. On the last day, trading volume increase by 1.16M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 2.01M shares were traded, amounting to approximately 756.23M.
SYK Technical Signals
SYK(Stryker Corp Corp) has 4 buy signals and 3 sell signals now. The current trend is consolidation starting from 2025-06-17. The total price change during this trend is +0.59%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of SYK over the last 5 trading days is 453.94M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
SYK Moving Average Analysis
Stryker Corp's overall moving average trend leans more bearish as of Monday, June 23, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $390.5184533333333, and $397.3333333333333. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $368.4682133333334, and $361.65333333333336. A break-down below any of these levels will issue sell signals.
SYK Short Selling Analysis
The short sale ratio of Stryker Corp(SYK) as of 17 Jun 2025 is 22.06%, rising from last trading day. With increasing price from 377.12 to 373.37. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Sell
3
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
18.012
Bullish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 < -100
-107.631
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
8.559
Bullish
Moving Average
Price crosses above 5-day SMA
--
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-5.51
Bearish
Momentum (10 days)
MOM_10 < 0
-7.54
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.755
Bearish
SYK Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Stryker Corp(SYK), our algorithm predicts SYK's 1-month price at $473.58, with an 26.1%upwardshift. Using a similarity score up to 93.43%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Stryker Corp (SYK.N) stock, as of Sunday, June 22, 2025 , forecasts a 26.1% change over the next month, based on its high correlation with ELTX.O stock patterns. The similarity between their price movements over the analyzed periods is 93.43%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
SYK
No Data
ELTX
Up: 26.1%Similarity: 93.43%
Name
Similarity
Up/Down
ELTX.O
93.43%
+26.10%
AMLX.O
93.10%
-20.63%
IESC.O
92.99%
-4.85%
CRNC.O
92.61%
+0.08%
GMRE.N
92.59%
+2.23%
OFS.O
92.15%
+0.58%
MDXG.O
92.10%
+13.56%
CFR.N
92.03%
-3.85%
CORZ.O
91.87%
-19.26%
KN.N
91.83%
-14.34%
SYK Seasonality Analysis
Based on SYK's historical stock price data across all years, the probability of a positive return in June is53.33%, suggesting it maybe an ideal month to invest in SYK. In contrast,Februaryoffers the highest probability of positive returns at69.23%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Stryker Corp (SYK.N) stock in February has the highest probability of a positive return (69.23%), while August has the lowest probability (46.15%).
Performance Seasonality
The chart shows Stryker Corp. (SYK)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Stryker Corp (SYK.N) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. SYK has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Stryker Corp (SYK.N) stock in a year?
The radar chart shows that buying Stryker Corp (SYK.N) stock in February has the highest probability of a positive return (69.23%), while August has the lowest probability (46.15%).
How has Stryker Corp. (SYK)'s stock price performed over the past three years?
SYK's stock price rose by 21.72% in 2023,increased by 21.54% in 2024, and went up by 4.69% in 2025.
Is SYK a buy based on overall technical signals summary?
SYK has 4 buy signals and 3 sell signals now. Overall the technical rating for SYK is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of SYK.
What is the trend of Stryker Corp (SYK)'s moving average?
Stryker Corp's overall moving average trend leans more bearish as of June 23 2025, with 2 negative signals and 2 positive signal.
What is price prediction for SYK stock next month?
The price prediction chart for Stryker Corp (SYK.N) stock, as of June 22 2025, forecasts a 26.1% change over the next month, based on its high correlation with ELTX stock patterns. The similarity between their price movements over the analyzed periods is 93.43%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for SYK Stock?
### **Price Prediction for SYK Stock in 2025**
The price target for SYK stock in 2025 is **$395**, driven by strong fundamentals and growth prospects.
- **Reason**: Stryker Corporation (SYK) demonstrates solid financial performance, with organic sales growth of 8-9% expected in 2025, supported by strategic acquisitions like Inari Medical. Analysts highlight its position in Ken Fisher's portfolio with a 24.22% upside potential, reflecting confidence in its market leadership and innovation in medical technology.
{RATING:symbol=SYK, type=0}
What is price prediction 2030 for SYK Stock?
Stryker Corporation (SYK) is expected to reach a price range of **$500 to $550 by 2030**, driven by its strong organic growth and strategic acquisitions in the growing medical technology sector. The stock's current valuation and analyst sentiment suggest continued confidence in its long-term prospects. However, high forward P/E ratios indicate potential volatility and elevated expectations.